iSpecimen is supporting a hospital laboratory by coordinating the collection of over 1,700 human biospecimens, including serum, plasma, cerebrospinal fluid, and urine, to validate a new chemistry analyzer for clinical use. The specimens cover a wide range of analytes and test results, allowing the hospital to thoroughly assess the analyzer's performance before clinical deployment. This project highlights iSpecimen's role in sourcing specialized biospecimens and its collaboration with healthcare institutions to advance laboratory technologies. Specimen collection is ongoing, with iSpecimen managing the process between involved organizations.
The story about iSpecimen supporting hospital validation of a new chemistry analyzer is presented here with relevant market data from Pluang's health sector as of Sep 29, 2026 19:14 WIB. Among 100 priced health-sector US stocks, 50 rose and 41 fell today. Notably, ADPT (Adaptive Biotechnologies Corp) gained 1.93% with a price of USD 29.06 and a typical hold time of 36 days, contrasting with PHG (Koninklijke Philips NV) which declined 1.47% to USD 24.74 and had a longer typical hold time of 83 days. CYTK (Cytokinetics Inc) also rose by 1.63% to USD 67.24 with a shorter hold time of 19 days.
Realty Income, a real estate investment trust, stands out with its monthly dividend payments and a strong history of 136 dividend increases since 1994, currently yielding about 5.9%. This provides investors with a steady income stream, despite the st...
Ethereum's price remained stable around $2,711 with minimal daily fluctuations, while network fees for simple ETH transfers dropped to about six cents due to low gas prices near 1 Gwei. This creates an unusually cheap opportunity for investors to mov...
Zcash developers have integrated the Tachyon project's recursive proof code into their Zakura Common cryptographic stack via the new Udon Rust crate, aiming to dramatically increase shielded transaction speeds. This upgrade targets processing over 50...
Avalanche (AVAX) surged 3.80% within one hour to $11.98 on September 29, extending its 24-hour gain to 14.28%. The price increase was recorded on Binance’s AVAX/USDT spot market. During this period, short-position liquidations across Binance, Bybit, ...
City Therapeutics is preparing for a U.S. IPO to raise funds for its RNAi therapeutic pipeline, including its lead candidate CITY-FXI aimed at treating thrombosis. The company has shown promising early Phase 1 results and benefits from strong partner...
